Journey Medical (DERM) grants 50,000 restricted stock units to director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Toledano Miranda Jayne reported acquisition or exercise transactions in this Form 4 filing.
Journey Medical Corp director Toledano Miranda Jayne received a grant of 50,000 shares of common stock in the form of restricted stock units on July 1, 2026 under the company’s 2015 Stock Plan. These RSUs vest in three annual installments: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030, and 16,667 shares on July 1, 2031.
Following this award, Toledano directly holds 168,618 shares of Journey Medical common stock, including restricted stock units that vest over various time periods. The grant reflects equity-based compensation rather than an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Toledano Miranda Jayne
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.0001 par value | 50,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $0.0001 par value — 168,618 shares (Direct, null)
Footnotes (1)
- On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031. Includes restricted stock units, which vest over various time periods.
Key Figures
RSUs granted: 50,000 shares
Vesting tranche 1: 16,666 shares
Vesting tranche 2: 16,667 shares
+3 more
6 metrics
RSUs granted
50,000 shares
Restricted stock units granted on July 1, 2026
Vesting tranche 1
16,666 shares
RSUs vesting on July 1, 2029
Vesting tranche 2
16,667 shares
RSUs vesting on July 1, 2030
Vesting tranche 3
16,667 shares
RSUs vesting on July 1, 2031
Holdings after grant
168,618 shares
Total direct common stock holdings after July 1, 2026 award
Grant price per share
$0.00 per share
Reported transaction price for RSU award
Key Terms
restricted stock units, 2015 Stock Plan, par value, vest
4 terms
restricted stock units financial
"the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2015 Stock Plan financial
"pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule"
par value financial
"Common Stock, $0.0001 par value"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
vest financial
"which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did Journey Medical Corp (DERM) director Toledano Miranda Jayne receive in this Form 4?
Director Toledano Miranda Jayne received a grant of 50,000 restricted stock units of Journey Medical Corp common stock on July 1, 2026 as equity-based compensation under the company’s 2015 Stock Plan, rather than through an open-market purchase.
What is the vesting schedule for the 50,000 RSUs reported by Journey Medical (DERM)?
The 50,000 restricted stock units vest over three years: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030, and 16,667 shares on July 1, 2031, subject to the terms of Journey Medical’s 2015 Stock Plan.
Was the Journey Medical (DERM) Form 4 transaction an open-market stock purchase or sale?
The Form 4 reports a grant of restricted stock units coded as a grant or award, not an open-market purchase or sale. The RSUs were awarded at a stated price of $0.00 per share as part of equity compensation.
Under which plan were the 50,000 Journey Medical (DERM) RSUs granted?
The 50,000 restricted stock units were granted pursuant to Journey Medical Corp’s 2015 Stock Plan, as amended, which governs the terms, vesting schedule, and other conditions for this equity compensation award.